Non-Medical Switching

Non-medical switching is when a PBM or health plan changes the drug that a patient is required to take for a specific condition mid-year, for reasons unrelated to the patient's clinical situation. The switch might be triggered by a new rebate contract with a different manufacturer, a formulary tier reshuffling, or the removal of a brand from the covered formulary altogether. The patient's clinical circumstances haven't changed — only the plan's economics have.

The practice has become more common as PBMs aggressively renegotiate formulary contracts each year. A patient stable on brand-name Advair for years might arrive at the pharmacy in January to find their plan now requires them to switch to a different inhaler brand, sometimes without prior notice to the prescriber. For many patients the switch is uneventful; for others — particularly those with well-managed complex conditions like severe asthma, epilepsy, or transplant medications — a switch can trigger clinical instability. Patient-advocacy groups have pushed for state laws requiring advance notice, medical-necessity exception pathways, and prohibitions on mid-year switching for stable patients. Several states have passed legislation limiting non-medical switching for certain drug categories. Employers can address this in plan design by requiring their PBM to grandfather stable patients on their current medication through the plan year.

The takeaway: if you're stable on a medication and receive a letter saying your plan is switching you to a different drug for non-clinical reasons, you can request a medical-necessity exception through your prescriber. Most plans have a formal exception pathway that's often granted for stable patients.